Mechanism of action and microbiological spectrum of quinupristin/dalfopristin;Wirkungsweise und mikrobiologisches spektrum von quinupristin-dalfopristin

Chemotherapie Journal, Supplement

Volumn 9, Issue 19, 2000, Pages 18-23

  Geiss, H K ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; METICILLIN; PENICILLIN DERIVATIVE; QUINUPRISTIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; CHLAMYDIA; DRUG MECHANISM; ENTEROBACTERIACEAE; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; MACROPHAGE; MORAXELLA CATARRHALIS; MYCOPLASMA; NEISSERIA; NONHUMAN; PENICILLIN RESISTANCE; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; REVIEW; RIBOSOME; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0034454138     PISSN: 09446486     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. RP 59500. A proposed mechanism for its bactericidal activity
2. A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas
3. Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods
4. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin
5. The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics
6. Inhibition of protein synthesis by streptogramins and related antibiotics
7. Antibacterial activity of quinupristin/dalfopristin
8. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium
9. Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing
10. Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae
11. Quinupristin/dalfopristin: Spectrum of activity, pharmacokinetics, and initial clinical experience
12. A review of in-vitro antibacterial activity of quinupristin/dalfbpristin against methicillin-susceptible and -resistant Staphylococcus aureus
13. Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes
14. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis
15. Post-antibiotic effect of RP 59599 with Staphylococcus aureus
16. Streptogramins. A unique class of antibiotics
17. Mechanism of action of streptogramins and macrolides
18. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp